Ultra Chiron Pharmaceuticals Pvt Ltd
Founded: 1993
Status: Active
Designation: Director
RS
Rajesh Biswanath Shrivastava - Profile
Rajesh Biswanath Shrivastava, Director, with 5 companies across 1 industry.
About
Rajesh Biswanath Shrivastava
Rajesh Biswanath Shrivastava has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Ultra Chiron Pharmaceuticals Pvt Ltd and Quixotic Pharma Private Limited. Formerly with 3 companies, such as Preet Remedies Limited and Quixotic Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
2
Past Companies
3
Total Affiliations
5
Oldest Company Age
32
Companies Associated with Rajesh Biswanath Shrivastava
Current Companies
Quixotic Pharma Private Limited
Founded: 2002
Status: Active
Designation: Director
Previous Companies
Preet Remedies Limited
Founded: 2005
Status: Active
Designation: Director
Quixotic Pharma Private Limited
Founded: 2002
Status: Active
Designation: Additional Director
Ultra Chiron Pharmaceuticals Pvt Ltd
Founded: 1993
Status: Active
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Rajesh Biswanath Shrivastava?
Rajesh Biswanath Shrivastava has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Ultra Chiron Pharmaceuticals Pvt Ltd and Quixotic Pharma Private Limited. Formerly with 3 companies, such as Preet Remedies Limited and Quixotic Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Rajesh Biswanath Shrivastava's role in current companies?
Rajesh Biswanath Shrivastava is associated with 2 companies as Director.
What industries does Rajesh Biswanath Shrivastava specialize in?
Rajesh Biswanath Shrivastava has expertise in General Business.
How many years of experience does Rajesh Biswanath Shrivastava have?
Rajesh Biswanath Shrivastava has 7 years in corporate governance.